tirzepatide kidneys Tirzepatide, HFpEF, and the Kidney: A Triangular Relationship Requiring Measurement of GFR, Not Guesses Tirzepatide and prevention of chronic

As someone on a GLP-1 journey, finding delicious, supportive options is key

Exploring the emerging research on GLP-1 receptor agonists and Parkinson's disease: understand the science, clinical trials, potential benefits, risks, and why these diabetes medications are being investigated for neuroprotection.

We sought to investigate the real-world impact of sodiumglucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in individuals with type 1 diabetes in relation to effect on blood glucose levels, adverse events and cardio-renal outcomes

Yes, PPI therapy can theoretically reduce Vyvanse (lisdexamfetamine) efficacy by altering gastric pH, which may affect the conversion of the prodrug to its a...